Dr. Matthew Schlenker
Matthew B. Schlenker is an Assistant Professor and University of Toronto Glaucoma, Cataract, & Anterior Segment surgeon at Kensington Eye Institute, Trillium Health Partners, and Toronto Western Hospital. He received his Bachelor’s Degree (Magna Cum Laude) in Economics from Yale University and then worked as a financial analyst at Bear Stearns and as a business analyst at McKinsey & Co. He received his MD (with Honours) and Ophthalmology training at the University of Toronto, where he was a Chief Resident. He then completed a Glaucoma and Advanced Anterior Segment Fellowship at Trillium Health Partners and a Master of Science in Epidemiology at the Harvard School of Public Health.
He is the Chair of Resident Research in the Department of Ophthalmology & Vision Sciences at U. of T. and sits on the Kensington Research Committee. He is a regular presenter at both local and international academic conferences and has published in Ophthalmology, American Journal of Ophthalmology, British Journal of Ophthalmology, Journal of Cataract and Refractive Surgery, among other journals.
Financial disclosure: Dr. Schlenker has/had an affiliation (financial or otherwise) with a commercial organization:
1.
Aeques
2.
Alcon
3.
Allergan
4.
Bausch
& Lomb
5.
Johnson
& Johnson
6.
Santen
7. Thea-Labtician
Sessions in which Dr. Matthew Schlenker participates
Saturday 17 June, 2023
Sessions in which Dr. Matthew Schlenker attends
Friday 16 June, 2023
Learning Objectives:At the end of this session, participants will be able to: Review common comorbid conditions present in cataract patientsDiscuss risk communication in cataract surgeryExplore the role of ergonomics in the workplace CanMEDS Roles: Medical expert, scholarXX
Authors: Diana Lucia Martinez1, Iqbal Ike Ahmed1, Matthew B. Schlenker2. 1Prism Eye Institute, 2Trilium Health Partners. Author Disclosures: D.L. Martinez: None. I. Ahmed: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Aequus: C - Ace Vision: C - Aerie Pharmaceuti...
Learning Objectives:At the end of this session, participants will be able to: Review the history and patient perceptions of ISBCSExplore the trends in IOL strategiesDiscuss premium cataract refractive surgery CanMEDS Roles: Medical expert, scholarXX
Authors: Matthew B. Schlenker1, Isra Hussein1, Tushar Srivastava2, Jyoti Sharma2, Iqbal Ike K. Ahmed1. 1University of Toronto, 2ConnectHEOR Limited. Author Disclosures: M.B. Schlenker: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Alcon, Allergan, ...
Saturday 17 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Elucidate the cause and mechanism of DVD.Identity indications of Light adjustable lensXX
Learning Objectives: At the end of this session, participants will be able to: Enhance surgical strategies for routine cataractsDevelop an approach to complex cataract surgery: techniques, strategies, and instrumentationCanMEDS Roles: Medical expert, scholarX
Implantation of an IOL in the absence of capsular support remains challenging for many surgeons. Intrascleral haptic fixation using the flanged, double needle (Yamane) technique allows the surgeon to scleral fixate a 3 piece IOL in the setting of complete zonular compromise. The technique leaves the conjunctiva and sclera relatively undisturbed compared to other scleral fixation techniques while also reducing surgical time. Attendees will ga...
Learning ObjectivesAt the end of this session, participants will be able to:Understand how various systemic medication influence glaucomaUnderstand how to manipulate wound healing may improve success in glaucoma surgeryAssess and Integrate various glaucoma surgeries in our management of glaucoma and be aware of some of the c...
Sunday 18 June, 2023
Learning Objectives:At the end of this session, participants will be able to:Understand current evaluation and intervention approaches in pediatric vision rehabilitation.Understand the role of organisms and the microbiome in corneal infectionsReview management strategies for mild to severe keratoconusXX
Learning ObjectivesAt the end of this session, participants will be able to:Understand the change from medication use to other options in glaucoma treatmentUnderstand the latest in laser treatment for glaucoma including the LiGHT and ZAP trials and how to integrate into clinical practiceAssess AI in glaucoma management
Learning ObjectivesAt the end of this session, participants will be able to:Understand and compare various novel devices for glaucoma surgical management including MIGSUnderstand outcomes and potential pitfalls of glaucoma surgeryUnderstand the best candidates for various glaucoma surgeriesCan...
Authors: Mohammad Karam1, Abdulmalik Alsaif2, Abdullah AlRefaie3, Mohammad Alazemi3, Abdulaziz Almazyed4, Rand Alazaz5, Nahla Alkhowaiter6, Ahmed Aldubaikhi7, Marko Popovic8, Ahmad Alali9, Matthew Schlenker8. 1AlBahar Eye Center, Ibn Sina Hospital, Ministry of Health, State of Kuwait, 2Walsall Healthcare NH...